PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF A SOLUBLE MOUSE INTERFERON-GAMMA RECEPTOR PRODUCED IN INSECT CELLS

被引:48
作者
FOUNTOULAKIS, M
SCHLAEGER, EJ
GENTZ, R
JURANVILLE, JF
MANNEBERG, M
OZMEN, L
GAROTTA, G
机构
[1] Hoffmann-La Roche Ltd, Central Research Units, Basel
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1991年 / 198卷 / 02期
关键词
D O I
10.1111/j.1432-1033.1991.tb16034.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The extracellular domain of the mouse interferon-gamma receptor comprising amino acids 17 - 243 of the protein was produced in Spodoptera frugiperda cells infected with a recombinant baculovirus. The receptor was mainly secreted into the culture medium and was purified to homogeneity in several hundred milligram amounts. The purification procedure involved four chromatography steps and delivered a soluble and active receptor with an overall recovery of 30%. From each purification run, two pools of soluble receptor with the same interferon-gamma binding capacity were isolated. Under reducing electrophoretic conditions the protein of pool I migrates as two bands of molecular masses 32 and 34 kDa and of pool II as two bands of 30 and 32 kDa. The soluble receptor of both pools carries a heterogeneous glycosylation. After deglycosylation it appears as one protein band of 27 kDa. N-linked carbohydrates contribute about 6 kDa and O-linked carbohydrates 1 kDa to its molecular mass. The nonreduced protein specifically binds interferon-gamma on ligand blots and in a solid-phase binding system and competes for the binding of radiolabeled interferon-gamma to the cell surface receptor. The soluble mouse interferon-gamma receptor exists as a monomer in physiological buffer and binds interferon-gamma in its dimeric form. It is stable at room temperature and against tryptic digestion, but is very sensitive to proteinase K digestion. The soluble mouse interferon-gamma receptor produced in the insect/baculovirus expression system may prove useful to study the function of interferon-gamma receptor as an antagonist of endogenous interferon-gamma in the treatment of immunological and inflammatory disorders.
引用
收藏
页码:441 / 450
页数:10
相关论文
共 31 条
[1]   PURIFICATION OF HUMAN GAMMA-INTERFERON RECEPTORS BY SEQUENTIAL AFFINITY-CHROMATOGRAPHY ON IMMOBILIZED MONOCLONAL ANTIRECEPTOR ANTIBODIES AND HUMAN GAMMA-INTERFERON [J].
AGUET, M ;
MERLIN, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (04) :988-999
[2]   MOLECULAR-CLONING AND EXPRESSION OF THE HUMAN INTERFERON-GAMMA RECEPTOR [J].
AGUET, M ;
DEMBIC, Z ;
MERLIN, G .
CELL, 1988, 55 (02) :273-280
[3]   PURIFICATION AND PARTIAL CHARACTERIZATION OF A RECEPTOR PROTEIN FOR MOUSE INTERFERON-GAMMA [J].
BASU, MT ;
PACE, JL ;
PINSON, DM ;
HAYES, MP ;
TROTTA, PP ;
RUSSELL, SW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (17) :6282-6286
[4]   PURIFICATION AND CHARACTERIZATION OF THE HUMAN INTERFERON-GAMMA RECEPTOR FROM PLACENTA [J].
CALDERON, J ;
SHEEHAN, KCF ;
CHANCE, C ;
THOMAS, ML ;
SCHREIBER, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4837-4841
[5]  
COFANO F, 1990, J BIOL CHEM, V265, P4064
[6]  
DOEBELI H, 1988, J BIOTECHNOL, V7, P199
[7]  
DOMINGO DL, 1988, J BIOL CHEM, V263, P13386
[8]  
FOUNTOULAKIS M, 1989, J IMMUNOL, V143, P3266
[9]  
FOUNTOULAKIS M, 1990, J BIOL CHEM, V265, P19758
[10]   DEVELOPMENT OF INTERFERON-GAMMA ANTAGONISTS AS AN EXAMPLE OF BIOTECHNOLOGY APPLICATION TO APPROACH NEW IMMUNOMODULATORS [J].
GAROTTA, G ;
OZMEN, L ;
FOUNTOULAKIS, M .
PHARMACOLOGICAL RESEARCH, 1989, 21 :5-17